-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QMINVNUqY1L5yKpAo/3drURCO3+GGhdv9YqcWhjo3Vgb5mTezLBVe+fVcMu7+MCq JNsWk3X1iufcHMc9eBcoyQ== 0001144204-08-061034.txt : 20081104 0001144204-08-061034.hdr.sgml : 20081104 20081104170033 ACCESSION NUMBER: 0001144204-08-061034 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20081031 FILED AS OF DATE: 20081104 DATE AS OF CHANGE: 20081104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NeoStem, Inc. CENTRAL INDEX KEY: 0000320017 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 222343568 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 420 LEXINGTON AVENUE STREET 2: SUITE 450 CITY: NEW YORK STATE: NY ZIP: 10170 BUSINESS PHONE: 212-584-4171 MAIL ADDRESS: STREET 1: 420 LEXINGTON AVENUE STREET 2: SUITE 450 CITY: NEW YORK STATE: NY ZIP: 10170 FORMER COMPANY: FORMER CONFORMED NAME: PHASE III MEDICAL INC/DE DATE OF NAME CHANGE: 20030819 FORMER COMPANY: FORMER CONFORMED NAME: CORNICHE GROUP INC /DE DATE OF NAME CHANGE: 19951117 FORMER COMPANY: FORMER CONFORMED NAME: FIDELITY MEDICAL INC DATE OF NAME CHANGE: 19951025 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VACZY CATHERINE M CENTRAL INDEX KEY: 0001177176 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33650 FILM NUMBER: 081161496 BUSINESS ADDRESS: STREET 1: IMCLONE SYSTEMS INC STREET 2: 180 VARICK STREET CITY: NEW YORK STATE: NY ZIP: 10014 BUSINESS PHONE: 631-574-4955 MAIL ADDRESS: STREET 1: C/O PHASE III MEDICAL, INC. STREET 2: 330 SOUTH SERVICE ROAD, SUITE 120 CITY: MELVILLE STATE: NY ZIP: 11747 4 1 v130608_ex.xml X0303 4 2008-10-31 0 0000320017 NeoStem, Inc. NBS 0001177176 VACZY CATHERINE M C/O NEOSTEM, INC. 420 LEXINGTON AVENUE, SUITE 450 NEW YORK NY 10170 0 1 0 0 VP and General Counsel Stock Options (right to buy) 1.13 2008-10-31 4 A 0 5000 0 A 2018-10-30 Common Stock, par value $.001 per share 5000 5000 D On October 31, 2008, the date of grant ("Grant Date"), the reporting person was granted an option to purchase shares of common stock of NeoStem, Inc. (the "Company"), pursuant and subject to the Company's 2003 Equity Participation Plan. These options were to vest upon the achievement of a specified business milestone, which milestone has been achieved. /s/ Catherine M. Vaczy 2008-11-04 -----END PRIVACY-ENHANCED MESSAGE-----